A hit-to-lead optimisation programme was carried out on the thiophenecarboxamide high throughput screening hits 1 and 2 resulting in the discovery of the potent and orally bioavailable IKK-2 inhibitor 22.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2004.03.058 | DOI Listing |
Publication Analysis
Top Keywords
discovery potent
8
potent orally
8
hit-to-lead studies
4
studies discovery
4
orally active
4
active thiophenecarboxamide
4
thiophenecarboxamide ikk-2
4
ikk-2 inhibitors
4
inhibitors hit-to-lead
4
hit-to-lead optimisation
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!